Delivery Order SPE2DB24D2101-SPE2DB24FKFDT
Award Date
7/11/24
Potential Completion Date
8/1/24
Potential Value
$26K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $9,296.97, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product, with a period of performance through March 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999, which serves as a...
This federal contract award, valued at $8,574.23, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of TAVALISSE 100 MG TABLET 60S, a pharmaceutical product. This award is a delivery order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a...
Amerisourcebergen Drug Corporation, as prime contractor, has been awarded a $8,257.25 firm fixed price delivery order by the Defense Logistics Agency Troop Support Medical (DLA) to supply 4561985318 TAVALISSE 150 MG TABLETS (60 count) for performance in Conshohocken, Pennsylvania from August 29, 2023 through September 20, 2023. The prime contractor, a subsidiary of Amerisourcebergen Corporation, will deliver the requested pharmaceutical products to the DLA without use of major subcontractors...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $27,600.00, is for the delivery of TAVALISSE 150 MG TABLET 60S, a pharmaceutical product. The award has an ultimate completion date of February 8, 2024 and is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that plays a critical...
This is a delivery order under a larger contract vehicle awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The delivery order is for $8,549.70 to provide Tavalisse 150 mg tablets. The order has a firm fixed price and a completion date of September 26, 2024. This contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, as well as a...
This federal contract award, valued at $17,148.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of 4565122826 - TAVALISSE 100 MG TABLET 60S, a pharmaceutical product, with a performance period through August 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of TAVALISSE 150 MG TABLET 60S. The delivery order, which does not have a set-aside designation, has a ceiling value of $29,240.00 and a performance period ending on June 4, 2024. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is a significant supplier of pharmaceutical products and medical supplies to...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $27,926.36 firm fixed-price delivery order covers the supply of "TALVEY 40 MG/ML VIALML" medical products, with a performance period through March 19, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,963.18 firm fixed-price delivery order is for the supply of 'TALVEY 40 MG/ML VIALML' medical products. The contract has an ultimate completion date of March 6, 2025 and is not set aside for any specific business category. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor. The $19,882.84 firm fixed price delivery order is for the supply of TIBSOVO 250 MG tablets. The contract has an ultimate completion date of May 14, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. This...